These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24862773)

  • 1. Predicting 1-month response of macular edema to intravitreal bevacizumab from 1-hour response.
    Ma DJ; Park KH; Woo SJ
    Can J Ophthalmol; 2014 Jun; 49(3):267-72. PubMed ID: 24862773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
    Nagaoka T; Sogawa K; Yoshida A
    Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema.
    Byeon SH; Kwon YA; Oh HS; Kim M; Kwon OW
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):387-94. PubMed ID: 17803438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
    Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
    Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy.
    Bakri SJ; Larson TA
    Semin Ophthalmol; 2015 Jul; 30(4):276-80. PubMed ID: 24251435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.
    Ahmadi AA; Chuo JY; Banashkevich A; Ma PE; Maberley DA
    Can J Ophthalmol; 2009 Apr; 44(2):154-9. PubMed ID: 19491948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Lu Y; Su L; Xu X
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.
    Wu L; Arevalo JF; Roca JA; Maia M; Berrocal MH; Rodriguez FJ; Evans T; Costa RA; Cardillo J;
    Retina; 2008 Feb; 28(2):212-9. PubMed ID: 18301025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.
    Farese E; Cennamo G; Velotti N; Traversi C; Rinaldi M; De Crecchio G
    Eur J Ophthalmol; 2014; 24(5):761-70. PubMed ID: 24585424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2009; 29(10):1396-403. PubMed ID: 19898177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Hwang HS; Chae JB; Kim JY; Kim DY
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
    Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
    Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of serous retinal detachment in branch retinal vein occlusion and response after primary intravitreal bevacizumab injection.
    Poon YC; Chen CH; Kuo HK; Chen YJ; Wu PC; Chen YH; Lee JJ
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):319-24. PubMed ID: 23145863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion.
    Kwon SI; Kim YW; Bang YW; Lee JY; Park IW
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):5-9. PubMed ID: 23237542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion.
    Yamaike N; Tsujikawa A; Sakamoto A; Ota M; Kotera Y; Miyamoto K; Kita M; Yoshimura N
    Retina; 2009 Jun; 29(6):757-67. PubMed ID: 19289982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.